Lista de obras - Vicente Estrada - Dominio Público Uruguay

A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.

artículo científico publicado en 2005

Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.

artículo científico publicado en 2014

Association of HIV-Infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis.

artículo científico publicado en 2012

Atrial natriuretic peptide in patients with acute myocardial infarction without functional heart failure

artículo científico publicado en 1991

CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control

artículo científico publicado en 2018

Cardiovascular disease risk in HIV infection and endothelial progenitor cells.

artículo científico publicado en 2012

Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain.

artículo científico publicado en 2015

Cardiovascular toxicity of abacavir: a clinical controversy in need of a pharmacological explanation.

artículo científico publicado en 2017

Cervical lipomatosis in HIV-infected patients: a case-control study

artículo científico publicado en 2007

Comparison of oxidative stress markers in HIV-infected patients on efavirenz or atazanavir/ritonavir-based therapy.

artículo científico publicado en 2014

Consensus document on the management of renal disease in HIV-infected patients.

artículo científico publicado en 2014

Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus

artículo científico publicado en 2014

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

artículo científico publicado en 2016

Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.

artículo científico publicado en 2012

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE):

article

Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.

artículo científico publicado en 2011

Dyslipidemia related to antiretroviral therapy.

artículo científico publicado en 2011

Effects of HIV, ART and prebiotics on the active fraction of the gut microbiota.

artículo científico publicado en 2018

Effects of Immunonutrition in Advanced HIV Disease: a Randomized Placebo Controlled Clinical Trial (Promaltia Study).

artículo científico publicado en 2018

Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study

artículo científico publicado en 2014

Efficacy of a dual therapy based on darunavir/ritonavir and etravirine in ART-experienced patients.

artículo científico publicado en 2014

Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.

artículo científico

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

artículo científico

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.

artículo científico

Executive summary of the consensus document on osteoporosis in HIV-infected individuals.

artículo científico

Executive summary of the consensus document on the management of renal disease in HIV-infected patients.

artículo científico publicado en 2014

Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

artículo científico publicado en 2014

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

artículo científico publicado en 2016

Factores clínicos y biomarcadores asociados a lesión vascular subclínica en la infección por el virus de la inmunodeficiencia humana

artículo científico publicado en 2012

Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.

artículo científico publicado en 2012

Functionally defective high-density lipoproteins are related to heightened T-cell activation in vertically HIV-infected adolescents.

artículo científico publicado en 2014

Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiative

artículo científico publicado en 2013

Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals

artículo científico publicado en 2016

Gut microbiota in diabetes and HIV: Inflammation is the link

scientific article published on 15 November 2018

HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases

artículo científico publicado en 2016

High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke

scientific article published on 01 December 1994

High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis

artículo científico

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.

artículo científico publicado en 2013

Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir

artículo científico publicado en 2015

Incipient Renal Impairment as a Predictor of Subclinical Atherosclerosis in HIV-Infected Patients

article

Increase of antiretroviral therapy-associated cardiovascular risk

artículo científico publicado en 2004

Interplay between gut microbiota metabolism and inflammation in HIV infection

article

Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.

artículo científico publicado en 2002

Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks.

artículo científico publicado en 2009

Long-term metabolic consequences of switching from protease inhibitors to efavirenz in therapy for human immunodeficiency virus-infected patients with lipoatrophy.

artículo científico publicado en 2002

Lp-PLA2 levels in HIV-infected patients.

artículo científico publicado en 2014

Mechanism of action and pharmacokinetics of rilpivirine

artículo científico publicado en 2013

Modulation of Saliva Microbiota through Prebiotic Intervention in HIV-Infected Individuals

artículo científico publicado en 2019

Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects

scientific article published on 10 July 2022

Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods

artículo científico publicado en 2012

Peak bone mass in young HIV-infected patients compared with healthy controls

artículo científico publicado en 2014

Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART.

artículo científico publicado en 2017

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

artículo científico publicado en 2016

Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

artículo científico publicado en 2000

Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain

article

Recomendaciones de GEAM/SPNS sobre el tratamiento de las alteraciones metabólicas y morfológicas en el paciente con infección por VIH

artículo científico publicado en 2006

Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy.

artículo científico publicado en 2016

Renal safety of tenofovir disoproxil fumarate in HIV-1 treatment-experienced patients with adverse events related to prior NRTI use: data from a prospective, observational, multicenter study

article

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

artículo científico publicado en 2009

Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.

artículo científico publicado en 2003

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

artículo científico publicado en 2016

Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.

artículo científico publicado en 2005

Smoking cessation in HIV patients: rate of success and associated factors.

artículo científico publicado en 2009

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.

artículo científico publicado en 2016

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

artículo científico publicado en 2014

Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study

article

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial.

artículo científico publicado en 2018

The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery

artículo científico publicado en 2013

The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects

artículo científico publicado en 2016

Tolerability of IM penicillin G benzathine diluted or not with local anesthetics, or different gauge needles for syphilis treatment: a randomized clinical trial

scientific article published on 23 October 2019

Vascular age calculation and equivalent risk factors in HIV-infected patients obtained from the D:A:D risk equation.

artículo científico publicado en 2016

Very low level viraemia and risk of virological failure in treated HIV-1-infected patients

artículo científico publicado en 2016

[An eosinophilic leukemoid reaction associated with anaplastic carcinoma of the thyroid]

artículo científico publicado en 1990

[Gastrointestinal bleeding in an AIDS patient]

artículo científico publicado en 2007

[Possible Epstein Barr virus encephalitis in a patient with HIV infection]

artículo científico publicado en 2007

[Red neck syndrome induced by erythromycin]

artículo científico publicado en 1992

[Stroke in the very old: myths and realities]

artículo científico publicado en 2012

Lista de obras de Vicente Estrada

A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.

Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals.

Association of HIV-Infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis.

Atrial natriuretic peptide in patients with acute myocardial infarction without functional heart failure

CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control

Cardiovascular disease risk in HIV infection and endothelial progenitor cells.

Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain.

Cardiovascular toxicity of abacavir: a clinical controversy in need of a pharmacological explanation.

Cervical lipomatosis in HIV-infected patients: a case-control study

Comparison of oxidative stress markers in HIV-infected patients on efavirenz or atazanavir/ritonavir-based therapy.

Consensus document on the management of renal disease in HIV-infected patients.

Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE):

Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.

Dyslipidemia related to antiretroviral therapy.

Effects of HIV, ART and prebiotics on the active fraction of the gut microbiota.

Effects of Immunonutrition in Advanced HIV Disease: a Randomized Placebo Controlled Clinical Trial (Promaltia Study).

Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study

Efficacy of a dual therapy based on darunavir/ritonavir and etravirine in ART-experienced patients.

Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection.

Executive summary of the consensus document on osteoporosis in HIV-infected individuals.

Executive summary of the consensus document on the management of renal disease in HIV-infected patients.

Executive summary of the recommendations on the evaluation and management of renal disease in human immunodeficiency virus-infected patients

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

Factores clínicos y biomarcadores asociados a lesión vascular subclínica en la infección por el virus de la inmunodeficiencia humana

Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.

Functionally defective high-density lipoproteins are related to heightened T-cell activation in vertically HIV-infected adolescents.

Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiative

Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals

Gut microbiota in diabetes and HIV: Inflammation is the link

HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases

High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke

High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.

Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir

Incipient Renal Impairment as a Predictor of Subclinical Atherosclerosis in HIV-Infected Patients

Increase of antiretroviral therapy-associated cardiovascular risk

Interplay between gut microbiota metabolism and inflammation in HIV infection

Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.

Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks.

Long-term metabolic consequences of switching from protease inhibitors to efavirenz in therapy for human immunodeficiency virus-infected patients with lipoatrophy.

Lp-PLA2 levels in HIV-infected patients.

Mechanism of action and pharmacokinetics of rilpivirine

Modulation of Saliva Microbiota through Prebiotic Intervention in HIV-Infected Individuals

Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects

Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods

Peak bone mass in young HIV-infected patients compared with healthy controls

Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain

Recomendaciones de GEAM/SPNS sobre el tratamiento de las alteraciones metabólicas y morfológicas en el paciente con infección por VIH

Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy.

Renal safety of tenofovir disoproxil fumarate in HIV-1 treatment-experienced patients with adverse events related to prior NRTI use: data from a prospective, observational, multicenter study

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.

Smoking cessation in HIV patients: rate of success and associated factors.

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial.

The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery

The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects

Tolerability of IM penicillin G benzathine diluted or not with local anesthetics, or different gauge needles for syphilis treatment: a randomized clinical trial

Vascular age calculation and equivalent risk factors in HIV-infected patients obtained from the D:A:D risk equation.

Very low level viraemia and risk of virological failure in treated HIV-1-infected patients

[An eosinophilic leukemoid reaction associated with anaplastic carcinoma of the thyroid]

[Gastrointestinal bleeding in an AIDS patient]

[Possible Epstein Barr virus encephalitis in a patient with HIV infection]

[Red neck syndrome induced by erythromycin]

[Stroke in the very old: myths and realities]